Overview

Safety of Fentanyl TAIFUN Treatment

Status:
Unknown status

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

Summary

A Multicenter, Multinational, Randomized, Open-Label, Parallel-Group Trial to Evaluate hte Safety of Fentanyl TAIFUN Treatment after titrated Dose Administration and the Current Breakthrough Pain Treatment for Breakthrough Pain in Cancer Patients on Maintenance Opioid Therapy

Phase:

Phase 3

Details

Lead Sponsor:

Akela Pharma, Inc.

Treatments:

Fentanyl
Hydromorphone
Morphine
Oxycodone